CY1107661T1 - Idraparinux (sanorg 34006) για θepαπεια και δευτepευουσα προληψη θρομβοεμβολικων φλεβικων πepιστατικων σε ασθενεις με εν τω βαθει φλεβικη θρομβωση - Google Patents
Idraparinux (sanorg 34006) για θepαπεια και δευτepευουσα προληψη θρομβοεμβολικων φλεβικων πepιστατικων σε ασθενεις με εν τω βαθει φλεβικη θρομβωσηInfo
- Publication number
- CY1107661T1 CY1107661T1 CY20061101002T CY061101002T CY1107661T1 CY 1107661 T1 CY1107661 T1 CY 1107661T1 CY 20061101002 T CY20061101002 T CY 20061101002T CY 061101002 T CY061101002 T CY 061101002T CY 1107661 T1 CY1107661 T1 CY 1107661T1
- Authority
- CY
- Cyprus
- Prior art keywords
- patients
- vein thrombosis
- deep vein
- therapeutic
- thomboevological
- Prior art date
Links
- 206010051055 Deep vein thrombosis Diseases 0.000 title abstract 2
- 206010047249 Venous thrombosis Diseases 0.000 title abstract 2
- 230000009863 secondary prevention Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- AJBMORBNKXNZSF-COSHMZDQSA-N (2s,3s,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3s,4s,5r,6r)-2-carboxy-4,5-dimethoxy-6-[(2r,3r,4s,5r,6s)-6-methoxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxy-3-[(2r,3r,4s,5r,6r)-3,4 Chemical compound OS(=O)(=O)O[C@@H]1[C@@H](OS(O)(=O)=O)[C@@H](OC)O[C@H](COS(O)(=O)=O)[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@H](O[C@H]3[C@@H]([C@@H](OC)[C@H](O[C@@H]4[C@@H]([C@@H](OC)[C@H](OC)[C@@H](COS(O)(=O)=O)O4)OC)[C@H](O3)C(O)=O)OC)[C@@H](COS(O)(=O)=O)O2)OS(O)(=O)=O)[C@H](C(O)=O)O1 AJBMORBNKXNZSF-COSHMZDQSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009424 thromboembolic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075374 | 2002-01-29 | ||
| EP03702514A EP1471924B1 (en) | 2002-01-29 | 2003-01-23 | Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107661T1 true CY1107661T1 (el) | 2013-04-18 |
Family
ID=27635850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20061101002T CY1107661T1 (el) | 2002-01-29 | 2006-07-19 | Idraparinux (sanorg 34006) για θepαπεια και δευτepευουσα προληψη θρομβοεμβολικων φλεβικων πepιστατικων σε ασθενεις με εν τω βαθει φλεβικη θρομβωση |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7709463B2 (https=) |
| EP (1) | EP1471924B1 (https=) |
| JP (1) | JP4870907B2 (https=) |
| CN (1) | CN1622813A (https=) |
| AR (1) | AR038320A1 (https=) |
| AT (1) | ATE323497T1 (https=) |
| AU (1) | AU2003205664B2 (https=) |
| BR (1) | BR0307196A (https=) |
| CA (1) | CA2472957C (https=) |
| CY (1) | CY1107661T1 (https=) |
| DE (1) | DE60304678T2 (https=) |
| DK (1) | DK1471924T3 (https=) |
| EA (1) | EA007204B1 (https=) |
| ES (1) | ES2262971T3 (https=) |
| MX (1) | MXPA04007310A (https=) |
| NO (1) | NO332699B1 (https=) |
| PE (1) | PE20030855A1 (https=) |
| PL (1) | PL207144B1 (https=) |
| PT (1) | PT1471924E (https=) |
| SI (1) | SI1471924T1 (https=) |
| TW (1) | TWI281861B (https=) |
| WO (1) | WO2003063881A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1831206B1 (en) * | 2004-12-01 | 2011-08-24 | OSI Pharmaceuticals, Inc. | N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| WO2012166611A2 (en) | 2011-05-27 | 2012-12-06 | Immune Disease Institute, Inc. | Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| CA3144968A1 (en) | 2019-07-09 | 2021-01-14 | Optimvia Llc | Methods for synthesizing anticoagulant polysaccharides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378829A (en) * | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
-
2003
- 2003-01-14 TW TW092100703A patent/TWI281861B/zh not_active IP Right Cessation
- 2003-01-23 PE PE2003000071A patent/PE20030855A1/es not_active Application Discontinuation
- 2003-01-23 EP EP03702514A patent/EP1471924B1/en not_active Expired - Lifetime
- 2003-01-23 US US10/502,706 patent/US7709463B2/en not_active Expired - Fee Related
- 2003-01-23 EA EA200400817A patent/EA007204B1/ru not_active IP Right Cessation
- 2003-01-23 CN CNA038028123A patent/CN1622813A/zh active Pending
- 2003-01-23 DE DE60304678T patent/DE60304678T2/de not_active Expired - Lifetime
- 2003-01-23 PL PL370557A patent/PL207144B1/pl unknown
- 2003-01-23 DK DK03702514T patent/DK1471924T3/da active
- 2003-01-23 PT PT03702514T patent/PT1471924E/pt unknown
- 2003-01-23 MX MXPA04007310A patent/MXPA04007310A/es active IP Right Grant
- 2003-01-23 BR BR0307196-0A patent/BR0307196A/pt not_active Application Discontinuation
- 2003-01-23 JP JP2003563570A patent/JP4870907B2/ja not_active Expired - Fee Related
- 2003-01-23 WO PCT/EP2003/000696 patent/WO2003063881A1/en not_active Ceased
- 2003-01-23 AU AU2003205664A patent/AU2003205664B2/en not_active Ceased
- 2003-01-23 CA CA2472957A patent/CA2472957C/en not_active Expired - Fee Related
- 2003-01-23 ES ES03702514T patent/ES2262971T3/es not_active Expired - Lifetime
- 2003-01-23 SI SI200330334T patent/SI1471924T1/sl unknown
- 2003-01-23 AT AT03702514T patent/ATE323497T1/de active
- 2003-01-28 AR ARP030100237A patent/AR038320A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 NO NO20043195A patent/NO332699B1/no not_active IP Right Cessation
-
2006
- 2006-07-19 CY CY20061101002T patent/CY1107661T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20050209175A1 (en) | 2005-09-22 |
| MXPA04007310A (es) | 2004-10-29 |
| NO332699B1 (no) | 2012-12-10 |
| DE60304678T2 (de) | 2007-04-05 |
| EA007204B1 (ru) | 2006-08-25 |
| DE60304678D1 (de) | 2006-05-24 |
| PE20030855A1 (es) | 2003-10-11 |
| CN1622813A (zh) | 2005-06-01 |
| HK1072361A1 (en) | 2005-08-26 |
| SI1471924T1 (sl) | 2006-10-31 |
| PT1471924E (pt) | 2006-09-29 |
| JP2005519919A (ja) | 2005-07-07 |
| CA2472957C (en) | 2011-09-13 |
| EA200400817A1 (ru) | 2005-02-24 |
| BR0307196A (pt) | 2004-11-03 |
| WO2003063881A1 (en) | 2003-08-07 |
| PL207144B1 (pl) | 2010-11-30 |
| TWI281861B (en) | 2007-06-01 |
| JP4870907B2 (ja) | 2012-02-08 |
| NO20043195L (no) | 2004-10-29 |
| TW200302104A (en) | 2003-08-01 |
| ATE323497T1 (de) | 2006-05-15 |
| AU2003205664B2 (en) | 2008-06-05 |
| EP1471924A1 (en) | 2004-11-03 |
| AR038320A1 (es) | 2005-01-12 |
| US7709463B2 (en) | 2010-05-04 |
| EP1471924B1 (en) | 2006-04-19 |
| PL370557A1 (en) | 2005-05-30 |
| CA2472957A1 (en) | 2003-08-07 |
| ES2262971T3 (es) | 2006-12-01 |
| DK1471924T3 (da) | 2006-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125544T1 (el) | Ενωσεις 1,2,4-οξαδιαζολοβενζοϊκου οξεος και η χρηση τους για μη νοηματικη καταστολη και στη θεραπευτικη αγωγη ασθενειας | |
| NO20034549D0 (no) | Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV | |
| CY1111478T1 (el) | Ενδειξη δοσολογιας προγεστερονης στην αντιμετωπιση τραυματικης εγκεφαλικης βλαβης | |
| CY1116494T1 (el) | Θεραπευτικη αγωγη θρομβοεμβολικων διαταραχων με ριβαροξαβανη | |
| CY1110019T1 (el) | Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες | |
| CY1116992T1 (el) | Μεθοδος θεραπειας της σκληρυνσης κατα πλακας αναστελλοντας τη δραση της il-17 | |
| CY1113051T1 (el) | Ιατρικα παρασκευασματα για τη θεραπευτικη αγωγη της ανεπαρκειας της α-γαλακτοσιδασης α | |
| CY1111613T1 (el) | Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv | |
| EA200500859A1 (ru) | Хинолинилпирролопиразолы | |
| CY1116464T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| CY1115286T1 (el) | Μεθοδοι θεραπευτικης αγωγης της νοσου toy parkinson | |
| CY1106774T1 (el) | Συνθεσεις φαρμακευτικων μεσων με βαση αλατα του τιοτροπιου και αλατα της σαλμετερολης | |
| DE69932733D1 (de) | Photosensitizer-konjugate zur zielrichtung von intrazellulare pathogene | |
| CY1112753T1 (el) | Θεραπευτικη αγωγη καρκινων του ανθρωπινου σωματος με τη χρηση toy ετ743 | |
| EA200400548A1 (ru) | Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi) | |
| CY1119790T1 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
| CY1107203T1 (el) | Χρηση αναστολεων της il - 18 για τη θεραπεια και/ή την προληψη καρδιακης νοσου | |
| CY1107461T1 (el) | Νεα μεθοδος διαπιδυσης | |
| EA200200502A1 (ru) | Способ введения ингибитора фосфодиэстеразы 4 | |
| EA200801731A1 (ru) | Составы и способы лечения тробмоцитемии | |
| CY1113488T1 (el) | Ενα φαρμακο για την δυο βαθμιδων περιεγχειρητικη θεραπεια συμπαγων ογκων δια ραδιοανοσοθεραπειας | |
| CY1107661T1 (el) | Idraparinux (sanorg 34006) για θepαπεια και δευτepευουσα προληψη θρομβοεμβολικων φλεβικων πepιστατικων σε ασθενεις με εν τω βαθει φλεβικη θρομβωση | |
| EA200300427A1 (ru) | Противоопухолевая терапия, включающая производные дистамицина | |
| SE9902597D0 (sv) | New use | |
| CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων |